2-Phenylpyrimidine
| Title | Journal |
|---|---|
| Self-ordering of metallogrid complexes via directed hydrogen-bonding. | Dalton transactions (Cambridge, England : 2003) 20121207 |
| Suppressive effects of liquid crystal compounds on the growth of U937 human leukemic monocyte lymphoma cells. | Cancer cell international 20120101 |
| Identification of specific and semi-specific SIRT inhibitors through computer-aided studies. | Aging 20110901 |
| Suppressive effects of liquid crystal compounds on the growth of the A549 human lung cancer cell line. | Investigational new drugs 20110801 |
| Molecular dynamics simulations of the liquid-crystal phases of 2-(4-butyloxyphenyl)-5-octyloxypyrimidine and 5-(4-butyloxyphenyl)-2-octyloxypyrimidine. | Physical review. E, Statistical, nonlinear, and soft matter physics 20100401 |
| Design of liquid crystals with 'de Vries-like' properties: frustration between SmA- and SmC-promoting elements. | Journal of the American Chemical Society 20100113 |
| Design and Synthesis of Imidazopyrimidine Derivatives as Potent iNOS Dimerization Inhibitors. | The open medicinal chemistry journal 20090101 |
| 2-Phenylpyrimidine skeleton-based electron-transport materials for extremely efficient green organic light-emitting devices. | Chemical communications (Cambridge, England) 20081130 |
| Synthesis and anticancer activity of cyclopalladated complexes containing 4-hydroxy-acridine. | Journal of inorganic biochemistry 20060901 |
| [Effects of liquid crystal-related compounds on human megakaryocytopoiesis and thrombopoiesis]. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20060601 |
| Co3(RL)2(hfac)6 ladder complex of 5-[4-(N-tert-butyl-N-aminoxyl)phenyl]pyrimidine. | Inorganic chemistry 20060320 |
| Chirality transfer in ferroelectric liquid crystals. | Accounts of chemical research 20011101 |
| [Selective inhibition of tyrosine kinases - a new therapeutic principle in oncology]. | Onkologie 20010901 |